Product Details for NDA 050679
MAXIPIME (CEFEPIME HYDROCHLORIDE)
EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CEFEPIME HYDROCHLORIDE
Proprietary Name: MAXIPIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050679
Product Number: 001
Approval Date: Jan 18, 1996
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
MAXIPIME (CEFEPIME HYDROCHLORIDE)
Proprietary Name: MAXIPIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050679
Product Number: 001
Approval Date: Jan 18, 1996
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CEFEPIME HYDROCHLORIDE
Proprietary Name: MAXIPIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050679
Product Number: 002
Approval Date: Jan 18, 1996
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
MAXIPIME (CEFEPIME HYDROCHLORIDE)
Proprietary Name: MAXIPIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050679
Product Number: 002
Approval Date: Jan 18, 1996
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CEFEPIME HYDROCHLORIDE
Proprietary Name: MAXIPIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050679
Product Number: 003
Approval Date: Jan 18, 1996
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: MAXIPIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050679
Product Number: 003
Approval Date: Jan 18, 1996
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information